IL17A and COVID-19: Sepsis patients with a history of severe COVID-19 exhibited elevated IL-6, IL-1β, and IL-17 levels, prolonged APTT, and increased 28-day mortality, indicating that past severe COVID-19 infection may contribute to systemic inflammation and coagulation disturbances, further worsening prognosis.